Liabilities and Equity in USD of Can-Fite BioPharma Ltd. from Q4 2018 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Can-Fite BioPharma Ltd. quarterly Liabilities and Equity history and change rate from Q4 2018 to Q2 2025.
  • Can-Fite BioPharma Ltd. Liabilities and Equity for the quarter ending 30 Jun 2025 was $7.72M, a 30.4% increase year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

Can-Fite BioPharma Ltd. Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $7.72M +$1.8M +30.4% 30 Jun 2025 6-K 28 Aug 2025
Q4 2024 $9.12M -$869K -8.7% 31 Dec 2024 6-K 28 Aug 2025
Q2 2024 $5.92M -$5.11M -46.3% 30 Jun 2024 6-K 29 Aug 2024
Q4 2023 $9.99M +$706K +7.61% 31 Dec 2023 20-F 14 Apr 2025
Q2 2023 $11M -$3.71M -25.2% 30 Jun 2023 6-K 31 Aug 2023
Q4 2022 $9.28M -$11M -54.2% 31 Dec 2022 20-F 28 Mar 2024
Q2 2022 $14.7M +$5.07M +52.3% 30 Jun 2022 6-K 25 Aug 2022
Q4 2021 $20.3M +$10.7M +113% 31 Dec 2021 20-F 30 Mar 2023
Q2 2021 $9.68M -$3.12M -24.4% 30 Jun 2021 6-K 26 Aug 2021
Q4 2020 $9.52M +$1.35M +16.5% 31 Dec 2020 20-F 24 Mar 2022
Q2 2020 $12.8M 30 Jun 2020 6-K 27 Aug 2020
Q4 2019 $8.17M +$222K +2.79% 31 Dec 2019 20-F 25 Mar 2021
Q4 2018 $7.95M 31 Dec 2018 6-K 01 Jun 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.